ArticleAnnals of gastroenterological surgery2024

Neoadjuvant S-1 and oxaliplatin plus bevacizumab therapy for high-risk locally advanced rectal cancer: A prospective multicenter phase II study.

Takuya Miura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.